$7.6 million has been granted to SkinVision, an Amsterdam-based skin cancer screening app, as backing from active investors Leo Pharma and PHS Fund, with supplementary aid from unnamed new sponsors which the company called "high net worth impact investors."
In response to this challenge, an innovative new warning implant system has been developed to detect four common cancers (lung, prostate, breast and colon). The level of calcium in a person’s blood would constantly be checked and if the calcium levels are too high, it warns the patient about the cancer onset by growing an artificial mole on the person’s skin.
The mobile app named Sunface is available for both iPhones and Android-based devices. With the app, the user takes a selfie and is then offered three categories named ‘daily sun protection’, ‘no sun protection’ and ‘weekly sunbed’.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.